Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Molecular Imaging and Biology
Published in: Molecular Imaging and Biology 2/2019

01-04-2019 | Magnetic Resonance Imaging | Special Topic

Summary of Imaging in 2020: Visualizing the Future of Healthcare with MR Imaging

Authors: Brooke A. Corbin, Alyssa C. Pollard, Matthew J. Allen, Mark D. Pagel

Published in: Molecular Imaging and Biology | Issue 2/2019

Login to get access

Abstract

The Imaging in 2020 meeting convenes biannually to discuss innovations in medical imaging. The 2018 meeting, titled “Visualizing the Future of Healthcare with MR Imaging,” sought to encourage discussions of the future goals of MRI research, feature important discoveries, and foster scientific discourse between scientists from a variety of fields of expertise. Here, we highlight presented research and resulting discussions of the meeting.
Literature
1.
2.
3.
Helm L, Morrow JR, Bond CJ et al (2018) Gadolinium-based contrast agents. In: Pierre VC, Allen MJ (eds) Contrast agents for MRI: experimental methods. The Royal Society of Chemistry, Croydon, pp 121–242
4.
Young SW, Qing F, Harriman A, Sessler JL et al (1996) Gadolinium (III) texaphyrin: a tumor selective radiation sensitizer that is detectable by MRI. Proc Natl Acad Sci U S A 93:6610–6615CrossRefPubMedPubMedCentral
5.
Raymond KN, Pierre VC (2005) Next generation, high relaxivity gadolinium MRI agents. Bioconjug Chem 16:3–8CrossRefPubMed
6.
Kanda T, Fukusato T, Matsuda M et al (2015) Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction: evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy. Radiology 276:228–232CrossRefPubMed
7.
Kanda T, Osawa M, Oba H et al (2015) High signal intensity in dentate nucleus on unenhanced T1-weighted MR images: association with linear versus macrocyclic gadolinium chelate administration. Radiology 275:803–809CrossRefPubMed
8.
Kanda T, Ishii K, Kawaguchi H, Kitajima K, Takenaka D (2014) High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology 270:834–841CrossRefPubMed
9.
McDonald RJ, McDonald JS, Kallmes DF et al (2015) Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology 275:772–782CrossRefPubMed
10.
Kanal E, Tweedle MF (2015) Residual or retained gadolinium: practical implications for radiologists and our patients. Radiology 275:630–634CrossRefPubMed
11.
Grobner T (2006) Gadolinium – a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 21:1104–1108CrossRefPubMed
12.
Andreucci M, Solomon R, Tasanarong A (2014) Side effects of radiographic contrast media: pathogenesis, risk factors, and prevention. Biomed Res Int 2014:741018PubMedPubMedCentral
13.
Thomsen HS (2009) Nephrogenic systemic fibrosis: history and epidemiology. Radiol Clin N Am 47:827–831CrossRefPubMed
14.
Wilson J, Gleghorn K, Seigel Q, Kelly B (2017) Nephrogenic systemic fibrosis: a 15-year retrospective study at a single tertiary care center. J Am Acad Dermatol 77:235–240CrossRefPubMed
15.
Wang Y, Alkasab TK, Narin O et al (2011) Incidence of nephrogenic systemic fibrosis after adoption of restrictive gadolinium-based contrast agent guidelines. Radiology 260:105–111CrossRefPubMed
16.
Cacheris WP, Quay SC, Rocklage SM (1990) The relationship between thermodynamics and the toxicity of gadolinium complexes. Magn Reson Imaging 8:467–481CrossRefPubMed
17.
Wedeking P, Kumar K, Tweedle MF (1992) Dissociation of gadolinium chelates in mice: relationship to chemical characteristics. Magn Reson Imaging 10:641–648CrossRefPubMed
18.
Idée J-M, Port M, Raynal I et al (2006) Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review. Fundam Clin Pharmacol 20:563–576CrossRefPubMed
19.
20.
Frenzel T, Lengsfeld P, Schirmer H et al (2008) Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 °C. Investig Radiol 43:817–828CrossRef
21.
22.
Caravan P, Das B, Dumas S et al (2007) Collagen-targeted MRI contrast agent for molecular imaging of fibrosis. Angew Chem Int Ed 46:8171–8173CrossRef
23.
Farrar CT, DePeralta DK, Day H et al (2015) 3D molecular MR imaging of liver fibrosis and response to rapamycin therapy in a bile duct ligation rat model. J Hepatol 63:689–696CrossRefPubMedPubMedCentral
24.
25.
26.
Lauffer RB (1987) Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design. Chem Rev 87:901–927CrossRef
27.
Loehr JA, Stinnett GR, Hernández-Rivera M et al (2016) Eliminating Nox2 reactive oxygen species production protects dystrophic skeletal muscle from pathological calcium influx assessed in vivo by manganese-enhanced magnetic resonance imaging. J Physiol 594:6395–6405CrossRefPubMedPubMedCentral
28.
Gale EM, Mukherjee S, Liu C et al (2014) Structure–redox–relaxivity relationships for redox responsive manganese-based magnetic resonance imaging probes. Inorg Chem 53:10748–10761CrossRefPubMedPubMedCentral
29.
30.
Gale EM, Caravan P (2018) Gadolinium-free contrast agents for magnetic resonance imaging of the central nervous system. ACS Chem Neurosci 9:395–397CrossRefPubMed
31.
32.
Jiang Y, Zheng W, Long L et al (2007) Brain magnetic resonance imaging and manganese concentrations in red blood cells of smelting workers: search for biomarkers of manganese exposure. NeuroToxicology 28:126–135CrossRefPubMed
33.
Finney K-LNA, Harnden AC, Rogers NJ et al (2017) Simultaneous triple imaging with two PARASHIFT probes: encoding anatomical, pH and temperature information using magnetic resonance shift imaging. Chem Eur J 23:7976–7989CrossRefPubMed
34.
Bleaney B (1972) Nuclear magnetic resonance shifts of solution due to lanthanide ions. J Magn Reson 8:91–100
35.
Suturina EA, Mason K, Geraldes CFGC et al (2017) Beyond Bleaney’s theory: experimental and theoretical analysis of periodic trends in lanthanide-induced chemical shift. Angew Chem Int Ed 56:12215–12218CrossRef
36.
Ward KM, Aletras AH, Balaban RS (2000) A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). J Magn Reson 143:79–87CrossRefPubMed
37.
Thorarinsdottir AE, Du K, Collins JHP, Harris TD (2017) Ratiometric pH imaging with a CoII 2 MRI probe via CEST effects of opposing pH dependences. J Am Chem Soc 139:15836–15847CrossRefPubMed
38.
Jeon I-R, Park JG, Haney CR, Harris TD (2014) Spin crossover iron (II) complexes as PARACEST MRI thermometers. Chem Sci 5:2461–2465CrossRef
39.
Du K, Harris TD (2016) A CuII 2 paramagnetic chemical exchange saturation transfer contrast agent enabled by magnetic exchange coupling. J Am Chem Soc 138:7804–7807CrossRefPubMed
40.
41.
Zhou J, Lal B, Wilson DA, Laterra J, van Zijl PCM (2003) Amide proton transfer (APT) contrast for imaging of brain tumors. Magn Reson Med 50:1120–1126CrossRefPubMed
42.
Zhou J, Payen J-F, Wilson DA et al (2003) Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat Med 9:1085–1090CrossRefPubMed
43.
44.
45.
Stares E, Rho J, Ahrens ET et al (2018) Fluorine-based contrast agents. In: Pierre VC, Allen MJ (eds) Contrast agents for MRI. The Royal Society of Chemistry, Croyden, pp 479–498
46.
Akazawa K, Sugihara F, Nakamura T et al (2018) Highly sensitive detection of caspase-3/7 activity in living mice using enzyme-responsive 19F MRI Nanoprobes. Bioconjug Chem 29:1720–1728CrossRefPubMed
47.
Schmeider AH, Caruthers SD, Keupp J et al (2015) Recent advances in 19Fluorine magnetic resonance imaging with perfluorocarbon emulsions. Engineering 1:475–489CrossRef
48.
Basal LA, Bailey MD, Romero J et al (2017) Fluorinated Eu (II)-based multimodal contrast agent for temperature- and redox-responsive magnetic resonance imaging. Chem Sci 8:8345–8350CrossRefPubMedPubMedCentral
49.
Srivastava K, Ferrauto G, Young VG Jr et al (2017) Eight-coordinate, stable Fe (II) complex as a dual 19F and CEST contrast agent for ratiometric pH imaging. Inorg Chem 56:12206–12213CrossRefPubMed
50.
Akazawa K, Sugihara F, Minoshima M et al (2018) Sensing caspase-1 activity using activatable 19F MRI nanoprobes with improved turn-on kinetics. Chem Commun 54:11785–11788CrossRef
51.
Nikolaou P, Goodson BM, Chekmenev EY (2015) NMR hyperpolarization techniques for biomedicine. Chem Eur J 21:3156–3166CrossRefPubMed
52.
Ardenkjæ-Larsen JH, Fridlund B, Gram A et al (2003) Increase in signal-to-noise ratio of >10,000 times in liquid-state NMR. Proc Natl Acad Sci U S A 100:10158–10163CrossRef
53.
Kettunen MI, Kennedy BWC, Hu D-E, Brindle KM (2013) Spin echo measurements of the extravasation and tumor cell uptake of hyperpolarized [1-13C] lactate and [1-13C]pyruvate. Magn Reson Med 70:1200–1209CrossRefPubMed
54.
Bankson JA, Walker CM, Ramirez MS et al (2015) Kinetic modeling and constrained reconstruction of hyperpolarized [1-13C]-pyruvate offers improved metabolic imaging of tumors. Cancer Res 75:4708–4717CrossRefPubMedPubMedCentral
55.
Walker CM, Chen Y, Lai SY, Bankson JA (2016) A novel perfused Bloch–McConnell simulator for analyzing the accuracy of dynamic hyperpolarized MRS. Med Phys 43:854–864CrossRefPubMedPubMedCentral
56.
Rodrigues TB, Serrao EM, Kennedy BWC et al (2014) Magnetic resonance imaging of tumor glycolysis using hyperpolarized 13C-labeled glucose. Nat Med 20:93–97CrossRefPubMed
57.
Allouche-Arnon H, Lerche MH, Karlsson M et al (2011) Deuteration of a molecular probe for DNP hyperpolarization – a new approach and validation for choline chloride. Contrast Media Mol Imaging 6:499–506CrossRefPubMed
58.
Ma D, Gulani V, Seiberlich N et al (2013) Magnetic resonance fingerprinting. Nature 485:187–192CrossRef
59.
Hamilton JI, Jiang Y, Ma D et al (2018) Investigating and reducing the effects of confounding factors for robust T1 and T2 mapping with cardiac MR fingerprinting. Magn Reson Imaging 53:40–51CrossRefPubMedPubMedCentral
60.
Mehta BB, Coppo S, McGivney DF et al (2018) Magnetic resonance fingerprinting: a technical review. Magn Reson Med 2018:1–22
61.
Wehrl HF, Judenhofer MS, Wiehr S, Pichler BJ (2009) Preclinical PET/MR: technological advances and new perspectives in biomedical research. Eur J Nucl Med Mol Imaging 36:S56–S68CrossRefPubMed
62.
Catana C, Drzezga A, Heiss W-D, Rosen BR (2012) PET/MRI for neurologic applications. J Nucl Med 53:1916–1925CrossRefPubMed
63.
Wehrl HF, Martirosian P, Schick F, Reischl G, Pichler BJ (2014) Assessment of rodent brain activity using combined [15O]H2O-PET and BOLD-fMRI. NeuroImage 89:271–279CrossRefPubMed
64.
Wehrl HF, Hossain M, Lankes K et al (2013) Simultaneous PET-MRI reveals brain function in activated and resting state on metabolic, hemodynamic and multiple temporal scales. Nat Med 19:1184–1190CrossRefPubMed
65.
Hofmann M, Steinke F, Scheel V et al (2008) MRI-based attenuation correction for PET/MRI: a novel approach combining pattern recognition and atlas registration. J Nucl Med 49:1875–1883CrossRefPubMed
66.
Gleich B, Weizenecker J (2005) Tomographic imaging using the nonlinear response of magnetic particles. Nature 435:1214–1217CrossRefPubMed
67.
Knopp T, Conolly SM, Buzug TM (2017) Recent progress in magnetic particle imaging: from hardware to preclinical applications. Phys Med Biol 62:E4–E7CrossRefPubMed
68.
69.
Kim E, Zhang J, Hong K et al (2011) Vascular phenotyping of brain tumors using magnetic resonance microscopy (μMRI). J Cereb Blood Flow Metab 31:1623–1636CrossRefPubMedPubMedCentral
70.
Calabrese E, Badea A, Cofer G, Qi Y, Johnson GA (2015) A diffusion MRI tractography connectome of the mouse brain and comparison with neuronal tracer data. Cereb Cortex 25:4628–4637CrossRefPubMedPubMedCentral
71.
Bassett DS, Brown JA, Deshpande V, Carlson JM, Grafton ST (2011) Conserved and variable architecture of human white matter connectivity. NeuroImage 54:1262–1279CrossRefPubMed
72.
Snyder ALS, Corum CA, Moeller S, Powell NJ, Garwood M (2014) MRI by steering resonance through space. Magn Reson Med 72:49–58CrossRefPubMed
Metadata
Title
Summary of Imaging in 2020: Visualizing the Future of Healthcare with MR Imaging
Authors
Brooke A. Corbin
Alyssa C. Pollard
Matthew J. Allen
Mark D. Pagel
Publication date
01-04-2019
Publisher
Springer International Publishing
Published in
Molecular Imaging and Biology / Issue 2/2019
Print ISSN: 1536-1632
Electronic ISSN: 1860-2002
DOI
https://doi.org/10.1007/s11307-019-01315-8

Other articles of this Issue 2/2019

Molecular Imaging and Biology 2/2019 Go to the issue

Research Article

Influence of Multidrug Resistance-Associated Proteins on the Excretion of the ABCC1 Imaging Probe 6-Bromo-7-[11C]Methylpurine in Mice

Research Article

Associations Between [18F]FDG-PET and Complex Histopathological Parameters Including Tumor Cell Count and Expression of KI 67, EGFR, VEGF, HIF-1α, and p53 in Head and Neck Squamous Cell Carcinoma

Brief Article

Imaging Pulmonary Foreign Body Reaction Using [125I]iodo-DPA-713 SPECT/CT in Mice

Research Article

SNAPshots of the MCHR1: a Comparison Between the PET-Tracers [18F]FE@SNAP and [11C]SNAP-7941

Research Article

Quantitative Intensity Harmonization of Dopamine Transporter SPECT Images Using Gamma Mixture Models

Review Article

Detection of Sentinel Lymph Nodes with Near-Infrared Imaging in Malignancies